SOX30 and AIDS dementia complex: The incidence of SOX30 over-expression was 31.33% (47/150) in ADC, 14.29% (10/70) in SCC, 29.35% (27/92) in clinical stage I, 26.19% (11/42) in clinical stage II and 13.64% (9/66) in clinical stage III+IV of NSCLC patients, respectively (Table 1).